News

Vir Biotechnology, Inc. and Alnylam Pharmaceuticals, Inc. announced the initiation of a Phase 1/2 study of VIR-2218, a novel, investigational RNA interference (RNAi) therapeutic for the…
Read More...

Machavert Pharmaceuticals, a drug development company focused on bioactive phospholipid therapeutics for the treatment of cancer, recently reported impressive preclinical results. The…
Read More...

AstraZeneca announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for Fasenra (benralizumab) for the treatment of Eosinophilic…
Read More...

The Mundipharma network of independent associated companies announced that the European Commission (EC) has granted approval for the use of Pelmeg (pegfilgrastim) as a treatment for…
Read More...

Shanghai Roche Pharmaceuticals and Ascletis BioScience jointly announce that starting from 1st Dec 2018, Ascletis and Roche will expand their partnership in viral Hepatitis. Following…
Read More...

Danish dermatology specialists LEO Pharma and California rare disease pioneers PellePharm announced a strategic development and commercialization collaboration to address unmet medical…
Read More...

OBI Pharma, Inc., a Taiwan biopharma company announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for OBI-888 for the treatment of Pancreatic…
Read More...

WuXi Biologics announced that construction of a global innovation center has commenced in the district of Fengxian in Shanghai. The new state-of-the-art biologics center will…
Read More...

Rare cancers inherently make it difficult to collect data, build clinical expertise and treat affected patients – challenges which are best addressed through collaboration in…
Read More...

Ligand Pharmaceuticals Incorporated announces it has entered into a worldwide OmniAb partnership with iMetabolic Biopharma Corporation (iMBP), an early stage biopharma company located…
Read More...

HitGen Ltd announced that the company has entered into a drug discovery research collaboration with Biogen to identify novel small molecule leads for targets of interest. In this…
Read More...

Evotec AG announced that it has entered into a research collaboration with Immuneering Corporation (“Immuneering”), a worldwide leader in data-driven drug discovery, to discover novel…
Read More...

Piramal Pharma Solutions announced the completion of its new cGMP kilo lab suite at its API (Active Pharmaceutical Ingredient) site in Ennore, Chennai, India. The suite will formally…
Read More...

Marken announced a new collaboration with RareChannels, a global web-based reference which allows manufactures of rare disease therapies and their affiliates to find customized logistic…
Read More...

Alvotech and Fuji Pharma announce that the two companies are entering into an exclusive partnership for the commercialization by Fuji Pharma of Alvotech’s biosimilar portfolio in Japan.…
Read More...

Sobi and Novimmune SA announced that the U.S. Food and Drug Administration (FDA) has approved Gamifant(emapalumab-lzsg), an interferon gamma (IFNγ) blocking antibody for the treatment…
Read More...

Cambrex Corporation announced that it has entered into a definitive agreement to acquire Avista Pharma Solutions (Avista), a contract development, manufacturing, and testing…
Read More...

GlaxoSmithKline plc announced the filing of a supplemental Biologics License Application (sBLA) to the US Food and Drug Administration (FDA) seeking an additional indication for the use…
Read More...

Immunocore Limited announces it has entered into a new partnership with Genentech, a member of the Roche Group, to expand an existing discovery collaboration. Genentech and…
Read More...

Ampersand Capital Partners announced that it has completed the acquisition of Pacific Biomarkers and merged it with existing portfolio company NEOMED-LABS. This merger brings together…
Read More...